Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 79, Issue 1, Pages -Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-021-04049-5
Keywords
Extracellular vesicles; Diabetes; Endothelial cell; Apoptosis; Ceramide; SMPD3
Categories
Funding
- medical faculty of the University of Bonn [2018-1A-07, 2020-2A-05]
- German Heart Foundation
- German Cardiac Society [DGK 16/2018]
- Ernst & Berta Grimmke Foundation [13/19]
- Deutsche Forschungsgemeinschaft [WE 4139/8-1, JA 2351/2-1, 397484323 TRR 259]
- Corona-Foundation
- Projekt DEAL
Ask authors/readers for more resources
C16 ceramide was found to be the most abundant ceramide in lEVs and significantly increased after hyperglycemic injury to HCAECs. lEVs from hyperglycemic HCAECs induced apoptosis in recipient cells, while native lEVs did not. Intercellular transfer of ceramide through lEVs was confirmed, and inhibition of nSMases abrogated the glucose-mediated effect on apoptosis in lEV-recipient cells.
Background Pro-apoptotic and pro-inflammatory ceramides are crucially involved in atherosclerotic plaque development. Local cellular ceramide accumulation mediates endothelial apoptosis, especially in type 2 diabetes mellitus, which is a major cardiovascular risk factor. In recent years, large extracellular vesicles (lEVs) have been identified as an important means of intercellular communication and as regulators of cardiovascular health and disease. A potential role for lEVs as vehicles for ceramide transfer and inductors of diabetes-associated endothelial apoptosis has never been investigated. Methods and Results A mass-spectrometric analysis of human coronary artery endothelial cells (HCAECs) and their lEVs revealed C16 ceramide (d18:1-16:0) to be the most abundant ceramide in lEVs and to be significantly increased in lEVs after hyperglycemic injury to HCAECs. The increased packaging of ceramide into lEVs after hyperglycemic injury was shown to be dependent on neutral sphingomyelinase 2 (nSMase2), which was upregulated in glucose-treated HCAECs. lEVs from hyperglycemic HCAECs induced apoptosis in the recipient HCAECs compared to native lEVs from untreated HCAECs. Similarly, lEVs from hyperglycemic mice after streptozotocin injection induced higher rates of apoptosis in murine endothelial cells compared to lEVs from normoglycemic mice. To generate lEVs with high levels of C16 ceramide, ceramide was applied exogenously and shown to be effectively packaged into the lEVs, which then induced apoptosis in lEV-recipient HCAECs via activation of caspase 3. Intercellular transfer of ceramide through lEVs was confirmed by use of a fluorescently labeled ceramide analogue. Treatment of HCAECs with a pharmacological inhibitor of nSMases (GW4869) or siRNA-mediated downregulation of nSMase2 abrogated the glucose-mediated effect on apoptosis in lEV-recipient cells. In contrast, for small EVs (sEVs), hyperglycemic injury or GW4869 treatment had no effect on apoptosis induction in sEV-recipient cells. Conclusion lEVs mediate the induction of apoptosis in endothelial cells in response to hyperglycemic injury through intercellular transfer of ceramides. [GRAPHICS] .
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available